Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Aligos Therapeutics Inc. ALGS

Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.


Top institutional share ownership of Aligos Therapeutics Inc

Name Shares Shares % change Value Value % change
EcoR1 Capital, LLC 3,948,360 0.0% $4,778 -43.7%
Vivo Capital, LLC 3,547,030 0.0% $4,292 -43.7%
Hillhouse Capital Advisors, Ltd. 2,365,064 0.0% $2,862 -43.7%
Versant Venture Management, LLC 2,320,381 0.0% $3 -50.0%
Baker Bros. Advisors Lp 2,076,400 0.0% $2,512 -43.7%
Novo Holdings A/S 1,950,000 0.0% $2,360 -43.7%
Tang Capital Management Llc 1,547,710 $1,873
Boxer Capital, LLC 1,526,048 0.0% $1,847 -43.7%
Adage Capital Partners Gp, L.l.c. 1,473,278 0.0% $1,783 -43.7%
Bank Of America Corp /de/ 1,137,771 -3.9% $1,377 -45.9%

Top institutional buyers of Aligos Therapeutics Inc

Name Shares % change Value % change Shares Value
Renaissance Technologies Llc 149.3% 40.3% 903,100 $1,093
Acadian Asset Management Llc 78.9% 0.8% 314,334 $380
VEXMX - Vanguard Extended Market Index Fund Investor Shares 3.9% -81.2% 246,820 $531
IBB - iShares Nasdaq Biotechnology ETF 1.1% -81.7% 205,801 $442

Top institutional sellers of Aligos Therapeutics Inc

Name Shares % change Value % change Shares Value
BlackRock Inc. -67.2% -81.5% 525,556 $636
FKASX - Federated Kaufmann Small Cap Fund Class A Shares -26.9% -73.0% 1,077,655 $1,272
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares -19.3% -85.4% 684,900 $1,473
Vanguard Group Inc -17.3% -53.4% 1,062,672 $1,286
Pivotal bioVenture Partners Investment Advisor LLC -15.2% -52.3% 743,215 $899
JAGLX - Janus Henderson Global Life Sciences Fund Class T -14.6% -84.5% 608,708 $1,309
Bank Of America Corp /de/ -3.9% -45.9% 1,137,771 $1,377
IWM - iShares Russell 2000 ETF -2.5% -82.4% 477,289 $1,026

Information provided by Fintel.io